The National Center for Radiation Research in Oncology – OncoRay is receiving around 1.1 million euros in funding from the Federal Ministry of Research, Technology and Space under the program “Nuclear Safety and Radiation Research” for the joint project MEDABIS-PRO. The funding will be provided for a period of four years, shared between the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the Carl Gustav Carus Faculty of Medicine at TUD Dresden University of Technology.
The project MEDABIS-PRO (“Effects of magnetic fields on dose delivery and biological radiation in MRI-guided proton therapy”) lies at the intersection of imaging, radiation physics, biology and clinical translation. It aims to elucidate questions related to MR-integrated proton therapy (MRiPT) and to drive the development of this innovative method forward. Further stated goals of the funding program include maintaining expertise and promoting junior researchers in the field of radiation research.
